Company / Operating Cash Flow
ADC Therapeutics SA Operating Cash Flow History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$141.2M
FY2025
5-year range
-$141.2M / -$118.7M
FY2023-FY2025
Trend
-18.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$138M to -$141M over the past 2 years.
Based on SEC 10-K filings.
-$141M in FY2025.
Declined from -$138M to -$141M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 18.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$141.2M | -18.9% |
| FY2024 | -$118.7M | +14.2% |
| FY2023 | -$138.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026